ELGX News Alert Endologix Inc (ELGX) 15.35 12/25/2014 11:47:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Endologix Inc (ELGX) 15.35 $ELGX

First Week Of August 2015 Options Trading For Endologix
at The Street - Wed Dec 24, 12:00PM CST
Investors in Endologix Inc. saw new options begin trading this week, for the August 2015 expiration.
ELGX: 15.35 (-0.06)

Volcano Acquired by Royal Philips for $1.2B: What Wall Street's Saying
at The Street - Wed Dec 17, 2:20PM CST
Volcano Corp. shares surged more than 50% on Wednesday after Royal Philips agreed to acquire the medical technology company for $1.2 billion.
BSX: 13.13 (+0.07), SPNC: 34.50 (+0.59), ABT: 45.70 (-0.02), PHG: 29.39 (-0.06), MDT: 74.08 (+0.31), TRIV: 13.47 (-0.40), VOLC: 17.95 (+0.02), STJ: 66.67 (+0.67), THOR: 32.81 (+0.74), HTWR: 72.62 (+0.02), ELGX: 15.35 (-0.06), ATRC: 18.76 (+0.13), NVDQ: 16.90 (+0.55)

Insider Trading Alert - MKSI, QTWW And ELGX Traded By Insiders
at The Street - Tue Dec 16, 10:45AM CST
Stocks with insider trader activity include MKSI, QTWW and ELGX
QTWW: 2.39 (-0.01), MKSI: 37.24 (-0.01), ELGX: 15.35 (-0.06)

Endologix to Participate in Two Investor Conferences in December
GlobeNewswire - Tue Nov 25, 8:07AM CST
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that Company management is scheduled to participate at two investor conferences in December. The first conference is the 26th Annual Piper Jaffray Healthcare Conference in New York, NY.
ELGX: 15.35 (-0.06)

Nellix Clinical Data From the EVAS FORWARD Global Registry Presented at 2014 VEITH Symposium
GlobeNewswire - Thu Nov 20, 9:11AM CST
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today the presentation of initial clinical data from the Company's EVAS FORWARD - Global Registry, a post-market study that prospectively enrolled patients with abdominal aortic aneurysms ("AAAs" who were treated with the Nellix(R) EndoVascular Aneurysm Sealing System ("Nellix EVAS System" . The study enrolled 300 patients under a protocol having no anatomical restrictions, and represented a broad range of AAA anatomies. The study includes core lab assessment of CT scans and independent physician adjudication of outcomes. The Nellix EVAS System is approved for investigational use only in the US.
ELGX: 15.35 (-0.06)

Endologix Completes Patient Enrollment in the Nellix(R) EVAS FORWARD-IDE Clinical Trial
GlobeNewswire - Tue Nov 18, 6:00AM CST
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has completed patient enrollment in the EVAS FORWARD-IDE clinical trial, the Company's U.S. pivotal clinical trial designed to evaluate the safety and effectiveness of the Nellix(R) EndoVascular Aneurysm Sealing System ("Nellix EVAS System" for the endovascular repair of infrarenal abdominal aortic aneurysms ("AAA" . Primary endpoint analysis results at one-year and beyond will be used to support the Company's premarket approval (PMA) application to the U.S. Food & Drug Administration (FDA) for the Nellix EVAS System.
ELGX: 15.35 (-0.06)

Post Earnings Update: Endologix Has Climbed 2.1% Higher in Past 2 Weeks (ELGX)
Comtex SmarTrend(R) - Mon Nov 17, 4:01PM CST
18 days ago, on October 30th, 2014, Endologix (NASDAQ:ELGX) reported its earnings. Analysts, on average, expected a loss of $0.13 per share on sales of $37.0 million. Endologix actually reported a loss of $0.13 per share on sales of $37.2 million, beating EPS estimates by $0.00 and matching revenue estimates. Shares of Endologix have climbed from $11.24 to $11.48, representing a gain of 2.1% since the company reported earnings 18 days ago.
ELGX: 15.35 (-0.06)

Endologix to Participate in Three Investor Conferences in November
GlobeNewswire - Thu Nov 06, 4:17PM CST
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that Company management is scheduled to participate at three investor conferences in November. The first conference is the Stephens 2014 Fall Conference in New York, NY.
ELGX: 15.35 (-0.06)

InsiderInsights.com Daily Round Up 11/5/14: ELGX, NS, BIOL, NHF
InsiderInsights - at Seeking Alpha - Thu Nov 06, 3:19AM CST

VR: 41.51 (+0.19), JBHT: 84.91 (-0.02), FCX: 22.91 (+0.07), BBY: 38.89 (-0.80), NS: 57.17 (+0.24), LL: 63.91 (-0.41), ELGX: 15.35 (-0.06), ENFC: 14.42 (+0.01), RCL: 82.36 (+0.16), LMCA: 34.41 (+0.18), SPW: 86.64 (-0.11), OPK: 9.63 (+0.21), BIOL: 2.63 (-0.07), IMI: 1.98 (-0.02), NHF: 11.23 (+0.01), SIX: 42.72 (+0.16), TWTR: 37.61 (+0.04), SCHW: 30.67 (+0.01)

Endologix to Host Investor Meeting on Thursday, November 20, 2014
GlobeNewswire - Mon Nov 03, 8:36AM CST
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today details for its 2014 investor meeting, which will be held on November 20, 2014 from 5:00 to 7:30 pm ET at the New York Hilton Midtown. The event will include a Company update, presentations from prominent physicians and a question and answer session with the physicians and Endologix management
ELGX: 15.35 (-0.06)

More on Endologix Q3 results
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 4:01PM CDT

ELGX: 15.35 (-0.06)

Endologix meets 3Q profit forecasts
Automated Insights - Fri Oct 31, 4:03AM CDT
IRVINE, Calif. (AP) _ Endologix Inc. (ELGX) on Friday reported a third-quarter loss of $13.9 million.
ELGX: 15.35 (-0.06)

Endologix's (ELGX) CEO John McDermott on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 8:54PM CDT

ELGX: 15.35 (-0.06)

Endologix EPS in-line, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 4:02PM CDT

ELGX: 15.35 (-0.06)

Endologix (ELGX) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 30, 3:55PM CDT

ELGX: 15.35 (-0.06)

Endologix Reports 12% Global Revenue Growth for the Third Quarter 2014
GlobeNewswire - Thu Oct 30, 3:50PM CDT
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, today announced financial results for the three and nine months ended September 30, 2014.
ELGX: 15.35 (-0.06)

Notable earnings after Thursday’s close
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 4:35PM CDT

ELLI: 41.40 (+0.81), AIV: 37.80 (-0.33), EPAY: 25.23 (-0.04), CPSI: 61.11 (-0.09), LNKD: 231.83 (+0.34), ADNC: 4.15 (+0.01), CODE: 34.55 (+0.64), HME: 66.47 (-0.43), ESIO: 7.76 (+0.13), HIL: 3.69 (-0.05), DGI: 30.85 (+0.27), AHT: 10.87 (-0.04), COLM: 44.76 (-0.62), AHS: 19.89 (+0.14), CSLT: 12.14 (+0.30), FRT: 136.26 (-0.13), DGII: 9.15 (+0.15), ADUS: 23.80 (-0.19), ESS: 210.72 (-1.86), EXPE: 89.01 (+0.09), IMPV: 51.87 (+1.18), CCI: 79.05 (-0.13), CPT: 75.44 (-0.56), GB: 49.34 (-0.36), AEGR: 21.59 (-0.27), ATEN: 4.29 (+0.01), ELGX: 15.35 (-0.06), AFFX: 9.80 (+0.05), CHE: 106.16 (+0.13), BCOV: 7.88 (-0.05), DCT: 35.96 (+0.21), ELX: 5.75 (+0.03), GNMK: 13.67 (+0.06), AXTI: 2.65 (-0.09), INT: 47.79 (-0.05), EGN: 64.33 (-0.02), EGO: 5.97 (+0.18), GMED: 24.37 (+0.44), GDOT: 20.42 (+0.25), KEG: 1.73 (+0.01), ISBC: 11.14 (+0.04), GRPN: 7.89 (-0.14), ALJ: 12.54 (+0.04), CTRL: 14.57 (-0.04), GPRO: 66.41 (+4.87), EMN: 76.80 (+0.04), IMMR: 9.45 (+0.47), CUBE: 22.59 (+0.08), BYI: 83.27 (unch), ATRC: 18.76 (+0.13), BYD: 12.28 (+0.14), FLDM: 32.31 (+0.30), BEAT: 10.15 (+0.09), FLR: 60.30 (-0.26), FLT: 149.17 (-0.93), EHTH: 27.13 (+0.97)

Endologix to Report Third Quarter 2014 Financial Results on October 30, 2014
GlobeNewswire - Thu Oct 09, 8:36AM CDT
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today details relating to the release of its third quarter 2014 financial results, which will take place on Thursday October 30, 2014 after the close of the market.
ELGX: 15.35 (-0.06)

Nasdaq stocks posting largest percentage decreases
AP - Tue Sep 30, 5:04PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
TTS: 8.87 (+0.04), ECYT: 6.33 (+0.24), PDFS: 14.97 (+0.03), CTCM: 4.89 (-0.20), WRES: 1.66 (-0.13), ADHD: 4.00 (+0.24), RTRX: 12.92 (+0.19), GWGH: 8.04 (-0.07), MTEX: 28.96 (unch), ELGX: 15.35 (-0.06), DWSN: 11.40 (+0.70), OTIC: 32.26 (+0.65), THRM: 38.25 (-0.11)

Nasdaq stocks posting largest volume increases
AP - Tue Sep 30, 5:04PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
PDFS: 14.97 (+0.03), IKAN: 0.31 (-0.01), SANW: 3.98 (-0.02), TIBX: 24.03 (+0.03), ALIM: 5.43 (-0.06), MOVE: 20.95 (-0.03), SPEX: 1.11 (+0.04), MBTF: 4.85 (+0.04), ELGX: 15.35 (-0.06), SMPL: 16.95 (+0.03)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mars Sets $2 Billion Debt Tender With Kellanova Notes

Updated Category News Views 108

A two-billion-dollar vacuum cleaner just switched on inside Mars’s debt stack, and the timing is anything but casual. On November 20, Mars fixed the pricing for cash tender offers spanning selected Mars and Kellanova senior notes, with holders facing a 5:00 p.m. New York deadline that same day. This is the kind of filing that looks like bond-market plumbing until you...

Continue Reading
U.S. Employers Signal a Deeper Multilingual Skills Gap

Updated Category News Views 101

A language gap rarely makes the loudest noise in an earnings call, yet it can quietly wreck a sales effort, a hiring plan, or a customer relationship. ACTFL's updated 2026 employer study puts some hard edges around that problem: U.S. businesses say multilingual capability is not a nice cultural accessory. It is increasingly part of operating the business. Demand Has Moved...

Continue Reading
AlphaPoint's Approval Device Targets AI Attack Risk

Updated Category News Views 45

A Separate Screen May Be Worth More Than Another Patch AlphaPoint is taking a fairly old security instinct and aiming it at a very current headache: if the laptop is lying to the employee, do not let the laptop have the final say. Its newly introduced Approval Device is dedicated hardware with its own display, built to let authorized staff inspect and approve sensitive...

Continue Reading
D-Wave Investors Face December 15 Lead Plaintiff Clock

Updated Category News Views 103

Quantum dreams met a very earthly spreadsheet problem at D-Wave this summer. The proposed securities class action against D-Wave Quantum Inc. puts a hard date on the issue for investors who bought shares between February 26 and August 25, 2026: December 15, 2026 is the deadline to seek lead-plaintiff status. That does not mean every holder needs to march into court. It...

Continue Reading
Water Damage Coverage Has More Traps Than Homeowners Think

Updated Category News Views 29

A wet basement does not care one bit whether the water arrived dramatically or dripped in for months. That ugly distinction, though, can decide whether a homeowner has an insurance claim or a repair bill that lands with a thud. Kathy Thurmond-Edwards, an insurance expert in Memphis, Tennessee, lays out the dividing lines plainly: sudden pipe failures may be treated very...

Continue Reading
Birkenstock’s Athens Stores Put Brand Control to Work

Updated Category News Views 76

A 62-square-meter shop on Ermou Street can say plenty about a brand’s ambitions. Birkenstock is opening its first two Greek stores in Athens, moving beyond its existing wholesale and retail-partner presence with locations it can shape from the floorboards up. The first site at Ermou 18 is stated to have opened on November 12, 2026; the announcement itself is dated...

Continue Reading
Trump's Reagan Forum Speech Puts Defense in Focus Again

Updated Category News Views 118

A December podium in Simi Valley has suddenly become a market-relevant appointment. The Ronald Reagan Presidential Foundation and Institute says President Donald J. Trump will deliver the keynote at the 2026 Reagan National Defense Forum on Friday, December 4, at 3:00 p.m. Pacific time, or 6:00 p.m. Eastern. That is the whole hard fact pattern so far. No agenda, no...

Continue Reading
PCS Rental Prep Is About Control Before Distance Hits

Updated Category News Views 99

A vacant house can turn into a long-distance headache with startling speed. For military homeowners preparing for a PCS move, the useful point in Rhonda Leahy's guidance is not glamorous: settle the boring operational stuff before the moving boxes, travel orders, and new-duty-station chaos swallow the calendar. Renting out a former home is not merely collecting enough...

Continue Reading
TCL CSOT's Oxide Leap Gives LCD a Sharper Fight Ahead

Updated Category News Views 73

Fifty-one point six is the number that makes this announcement worth chewing on. TCL CSOT says it has moved ultrahigh-mobility oxide technology into mass production on an 8.6-generation line, clearing the 50 cm² V?¹ s?¹ threshold that has largely belonged to lab-talk and presentation slides. For display people, that is not decorative science. It could change the old...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 62

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading

Top 5 Most Recently Viewed Articles

Redsun Properties Faces $350 Million Bond Payment Crisis Ahead

Updated Category News Views 189

Redsun Properties Announces Inability to Pay Bond Chinese property developer Redsun Properties has communicated its inability to meet a $350 million bond payment, which is due shortly. This situation has raised considerable concern within the financial markets as it highlights the ongoing issues facing property developers in China. Details of the Bond Issue This bond,...

Continue Reading
Etruscus Resources Unveils Promising Findings at Zappa Target

Updated Category News Views 135

Etruscus Resources Makes Progress at Key Exploration Sites Etruscus Resources Corp. is thrilled to report on the encouraging findings from its exploration program at the Rock & Roll Property. This property is situated in the Golden Triangle region, known for its wealth of mineral resources. The exploration program, which included comprehensive rock sampling and geological...

Continue Reading
MetLife's Strategic Focus: Navigating Q3 2024 Earnings

Updated Category News Views 1091

MetLife Announces Q3 2024 Results and New Frontier Strategy In the third quarter of 2024, MetLife, Inc. (MET) reported adjusted earnings of $1.4 billion, translating to $1.93 per share. This reflects a decline from previous year figures, yet a 12% year-to-date increase in adjusted earnings per share (EPS) excluding notable items. The insurance powerhouse has seen positive...

Continue Reading
VEON Invests in Ukraine: Commitment to Digital Growth

Updated Category News Views 125

VEON's Commitment to Investing in Ukraine VEON Ltd. (NASDAQ: VEON), a leading global digital operator, has recently made significant news with its promise to enhance Ukraine’s telecommunications infrastructure. In collaboration with its fully-owned subsidiary, Kyivstar, VEON participated in the 2024 Yalta European Strategy (YES) Annual Meeting. At this event, the focus...

Continue Reading
Expanding Diabetes Care: From Monitoring to Change

Updated Category News Views 44

Breaking Ground at the AGP & DTx Summit Diabetes management ain't what it used to be, and the 4th AGP & DTx Summit in Shenzhen gave us an eyeful of change. Under the banner "Beyond Glucose," experts from all corners came together to talk shop about Continuous Glucose Monitoring (CGM) and how it might shake up diabetes care. CGM: More Than a Gadget See, CGM's not just a...

Continue Reading